Johnson & Johnson (NYSE: JNJ) reported third-quarter 2021 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported revenue
Categories
Medical Devices
Abbott (ABT) bets on product mix to stay strong. Should you buy the stock?
The healthcare industry remains stressed despite a marked improvement in the pandemic situation, with patient visits increasing steadily and elective procedures resuming.
IPO news: Here’s what to know when Paragon 28 goes public this week
The medical device industry is witnessing a rebound in 2021 after seeing a dip last year amid the pandemic and it is
Medtronic PLC (MDT) Q1 2022 Earnings Call Transcript
Medtronic PLC (NYSE: MDT) Q1 2022 earnings call dated Aug. 24, 2021 Corporate Participants: Ryan Weispfenning -- Vice President and Head of Investor Relations
IPO Alert: What investors need to know about Procept BioRobotics’ upcoming market debut
The medical device market has been in the spotlight ever since coronavirus tightened its grip across the world last year as the
Should you buy Agilent Technologies (A) stock ahead of next week’s earnings?
The impact of the COVID crisis on Agilent Technologies, Inc. (NYSE: A), a leading provider of medical diagnostic devices, has been relatively
Is it the right time to invest in Abiomed (ABMD) stock?
Medical devices like ventilators and personal protective equipment are in high demand during the pandemic and their shortage often adds to the
Abiomed, Inc. (ABMD) Q1 2022 Earnings Call Transcript
Abiomed, Inc. (NASDAQ: ABMD) Q1 2022 earnings call dated Aug. 05, 2021 Corporate Participants: Todd A. Trapp -- Vice President and Chief Financial Officer
Boston Scientific Corp (BSX) Q2 2021 Earnings Call Transcript
Boston Scientific Corp. (NYSE: BSX) Q2 2021 earnings call dated Jul. 27, 2021 Corporate Participants: Lauren Tengler -- Investor Relations Michael F. Mahoney -- Chairman and
Abbott Laboratories (ABT) Q2 2021 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q2 2021 earnings call dated Jul. 22, 2021 Corporate Participants: Scott Leinenweber -- Vice President of Investor Relations, Licensing and
Medtronic PLC (MDT) Q4 2021 Earnings Call Transcript
Medtronic PLC (NYSE: MDT) Q4 2021 earnings call dated May 27, 2021 Corporate Participants: Ryan Weispfenning -- Vice President, Investor Relations Karen L. Parkhill -- Executive
Infographic: How Medtronic (MDT) performed in Q4 financial results
Medtronic plc (NYSE: MDT) reported fourth-quarter 2021 earnings results today. Worldwide revenue was $8.2 billion, up by 37% on a reported basis
SmileDirectClub (SDC) bets on rapid telemedicine-adoption to drive growth
The adoption of telemedicine accelerated in recent months, especially after the pandemic-related shelter-in-place orders came into effect. The trend will likely continue
Becton Dickinson & Co. (BDX) Q2 2021 Earnings Call Transcript
Becton Dickinson & Co. (NYSE: BDX) Q2 2021 earnings call dated May. 06, 2021. Corporate Participants: Kristen M. Stewart -- Investor Relations
Abiomed, Inc. (ABMD) Q4 2021 Earnings Call Transcript
Abiomed, Inc. (NASDAQ: ABMD) Q4 2021 earnings call dated Apr. 29, 2021 Corporate Participants: Todd A. Trapp -- Vice President and Chief Financial Officer
Boston Scientific Corp. (BSX) Q1 2021 Earnings Call Transcript
Boston Scientific Corp. (NYSE: BSX) Q1 2021 earnings call dated Apr. 28, 2021 Corporate Participants: Susie Lisa -- Vice President, Investor Relations Michael F.
Intuitive Surgical (ISRG): Here’s the main theme behind Q1 results and for the year ahead
Shares of Intuitive Surgical Inc. (NASDAQ: ISRG) were up over 10% on Wednesday. The stock has gained 74% over the past 12
Edwards Lifesciences Corp. (EW) Q1 2021 Earnings Call Transcript
Edwards Lifesciences Corp. (NYSE: EW) Q1 2021 earnings call dated Apr. 20, 2021 Corporate Participants: Mark Wilterding -- Vice President, Investor Relations Michael A.
Key highlights from Intuitive Surgical (ISRG) Q1 2021 earnings results
Intuitive Surgical, Inc. (NASDAQ: ISRG) reported first quarter 2021 earnings results today. Revenues increased 18% year-over-year to $1.29 billion, driven by growth
Abbott Laboratories (ABT) Earnings: 1Q21 Key Numbers
Abbott Laboratories (NYSE: ABT) reported first quarter 2021 earnings results today. Sales increased 35.3% year-over-year to $10.5 billion. On an organic basis,
The worst seems to be over for Boston Scientific. Is the stock a buy?
The pandemic has had a mixed impact on the healthcare sector since its outbreak more than a year ago, putting the emergency